Should intensive cholesterol lowering play a role in the management of acute coronary syndromes?
- 1 October 2000
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 86 (8) , 35-42
- https://doi.org/10.1016/s0002-9149(00)01226-1
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Long-Term Treatment with a Platelet Glycoprotein-Receptor Antagonist after Percutaneous Coronary RevascularizationNew England Journal of Medicine, 2000
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Rationale and Design of the Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering (MIRACL) Study That Evaluates Atorvastatin in Unstable Angina Pectoris and in Non–Q-Wave Acute Myocardial InfarctionThe American Journal of Cardiology, 1998
- Comparative effect of pravastatin and simvastatin on platelet-thrombus formation in hypercholesterolemic coronary patientsJournal of the American College of Cardiology, 1996
- Comparison of the effect of heparin and aspirin versus aspirin alone on transient myocardial ischemia and in-hospital prognosis in patients with unstable anginaJournal of the American College of Cardiology, 1994
- Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectorisThe Lancet, 1992
- Aspirin, Heparin, or Both to Treat Acute Unstable AnginaNew England Journal of Medicine, 1988
- Aspirin, Sulfinpyrazone, or Both in Unstable AnginaNew England Journal of Medicine, 1985
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983
- Effect of Cholesterol on Production of Thromboxane B2by Platelets in VitroNew England Journal of Medicine, 1980